Opendata, web and dolomites

PUPILOSCOPE SIGNED

Pupiloscope, a Neuro-Critical Care Device, Enabling Quantitative, Real-Time, Pupillary Monitoring and Assessment of Patients with Neurotrauma and Head Injuries.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PUPILOSCOPE project word cloud

Explore the words cloud of the PUPILOSCOPE project. It provides you a very rough idea of what is the project "PUPILOSCOPE" about.

incorporating    error    regulatory    potentially    hospital    direct    victims    billion    relatives    annum    monitoring    clinicians    doctors    quantitative    vivo    markets    healthcare    societal    positively    unmet    42    sales    medical    device    eyes    validation    prevent    suffer    triage    critical    approval    disability    threatening    million    33    reg    worldwide    leaders    global    care    economics    ready    patient    brain    functional    accurate    impacting    neuro    clinically    head    traumatic    shining    proven    launch    prone    subjective    paramedics    successfully    alone    injury    light    skill    emergency    breakthrough    people    tbi    forecasts    industry    levels    globally    mild    an    life    seek    engineers    death    experts    manufacturing    estimate    pupillary    reducing    finalisation    approved    prototype    solution    quick    health    society    young    pupiloscope    outcomes    nurses    medicating    clinical    time    trl    injuries    opinion    secondary    ce    human    patients   

Project "PUPILOSCOPE" data sheet

The following table provides information about the project.

Coordinator
VIVO SMART MEDICAL DEVICES LTD 

Organization address
address: 6 EDISON VILLAGE NOTTINGHAM SCIENCE TECHNOLOGY PARK
city: NOTTINGHAM
postcode: NG7 2RF
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.pupiloscope.com
 Total cost 1˙250˙911 €
 EC max contribution 875˙637 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIVO SMART MEDICAL DEVICES LTD UK (NOTTINGHAM) coordinator 875˙637.00

Map

 Project objective

An estimated 42 million people Worldwide suffer a Head Injury (2.5 million in the EU) that can lead to Mild or Traumatic Brain Injury (TBI). It is a major cause of death and disability, especially in young people, impacting victims and relatives, with significant costs to society, estimated at €33 Billion per annum in Europe alone.

Pre-Hospital and Emergency Care Neuro-Monitoring, including pupillary assessment, is critical in the processes of triage, management and medicating patients to prevent secondary injury to the brain. However, the current method of shining a light into a patient's eyes, in order to estimate pupillary response, is subjective and prone to human error.

The solution is Pupiloscope®, enabling Accurate, Real-time, Quantitative Pupillary Monitoring and Assessment for patients with potentially life threatening head injuries. Pupiloscope is a breakthrough technology that will positively impact clinical pathways as well as patient outcomes. It is quick, simple, and easy to use by Doctors, Nurses and Paramedics of all skill levels. Through collaboration with industry experts, key opinion leaders, engineers and Emergency Care based clinicians, who identified the unmet clinical need, ViVO has successfully developed a functional prototype to TRL 6.

As a direct result of this project, Pupiloscope forecasts sales of €20 Million within 5 years of product launch, improving patient outcomes and reducing both the societal and costs of care in the EU and Globally by an estimated €2 Billion per annum.

This project will seek to develop Pupiloscope into a clinically proven, manufacturing ready and CE approved medical device; incorporating technology finalisation, regulatory approval, health economics, clinical testing and validation, therefore enabling product launch and sales to the EU and Global Emergency Care healthcare markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PUPILOSCOPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PUPILOSCOPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

LTS (2020)

LEARNING TO SLEEP: INCREASING HEALTH THROUGH BETTER SLEEP

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More